Clinical trial
Psychopharmacology of Psilocybin in Cancer Patients
NCT00465595 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00465595 |
|---|---|
| Title | Psychopharmacology of Psilocybin in Cancer Patients |
| Official title | Psychopharmacology of Psilocybin in Cancer Patients |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | Heffter Research Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Depressive Symptoms, Anxiety, Cancer |
| Intervention type | Drug |
| Interventions | psilocybin |
| Enrollment | 56 |
| Start date | Apr 1, 2007 |
| Primary completion | Dec 1, 2014 |
| Completion | Dec 1, 2016 |
| First posted | Apr 25, 2007 |
| Last update posted | Jul 19, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: